Mnguni Malitsatsi J, Michael Joseph P, Lemmerer Andreas
Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Private Bag 3, Johannesburg, Gauteng, PO Wits 2050, South Africa.
Acta Crystallogr C Struct Chem. 2018 Jun 1;74(Pt 6):715-720. doi: 10.1107/S2053229618006861. Epub 2018 May 23.
An analysis and classification of the 2925 neutral binary organic cocrystals in the Cambridge Structural Database is reported, focusing specifically on those both showing polymorphism and containing an active pharmaceutical ingredient (API). The search was confined to molecules having only C, H, N, O, S and halogens atoms. It was found that 400 out of 2925 cocrystals can be classified as pharmaceutical cocrystals, containing at least one API, and that of those, 56 can be classified as being polymorphic cocrystals. In general, the total number of polymorphic cocrystal systems of any type stands at 125. In addition, a new polymorph of the pharmaceutical cocrystal theophylline-3,4-dihydroxybenzoic acid (1/1), CHNO·CHO, is reported.
报道了对剑桥结构数据库中2925种中性二元有机共晶体的分析和分类,特别关注那些既表现出多晶型又含有活性药物成分(API)的共晶体。搜索仅限于仅含有碳、氢、氮、氧、硫和卤素原子的分子。结果发现,2925种共晶体中有400种可归类为药物共晶体,至少含有一种API,其中56种可归类为多晶型共晶体。一般来说,任何类型的多晶型共晶体系统总数为125种。此外,还报道了药物共晶体茶碱-3,4-二羟基苯甲酸(1/1),CHNO·CHO的一种新的多晶型物。